NSEOptions to purchase securities1d ago · 24 Sept 2026, 04:49 pm
Options to purchase securities
Thyrocare Technologies Limited · THYROCARE
✦ AI Summaryoptions
Thyrocare Technologies Limited has informed the Exchange about Grant of Options under Thyrocare Employee Stock Option Scheme, where 1,92,000 options were granted to eligible employees at an exercise price of Rs. 10/- per Option.
Analysis Scores
Earnings Impact2/10
Growth Catalyst3/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Thyrocare Technologies Limited has informed the Exchange about Grant of Options under Thyrocare Employee Stock Option Scheme.
Attachments (1)
📄pdf
Download →
THYROCARE_24092026164919_SE_ESOS_Grant.pdf
View document text
September 24, 2026
The National Stock Exchange of India Limited BSE Limited
Exchange Plaza Phiroze Jeejeebhoy Towers
B(SaYnMdeBrOa LK:u TrlHaY CRoOmCpAleRxE, ) D(SaClaRlI SPt rCeOeDt, E 539871)
B andra (E), Mumbai - 400051 Mumbai- 400001
Sub: Grant of Employee Stock Options (“Options”) under Thyrocare Employee Stock
Option Scheme (“Scheme”)
Ref: Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure
Requirements) Regulations, 2015 ("Listing Regulations")
Dear Sir/Madam,
Pursuant to the provisions of Regulation 30 of Listing Regulations, we wish to inform that the
Members of Nomination and Remuneration Committee (“NRC”) of the Board of Directors of
Thyrocare Technologies Limited (“Company”), have approved and granted 1,92,000 number
of Options to the eligible employees of the Company at an exercise price of Rs. 10/- per Option
under the Thyrocare Employee Stock Option Scheme (“Scheme”) today, Thursday, September
24, 2026 at 03:49 P.M. The Options shall vest subject to the fulfillment of the applicable
vesting conditions.
Further the details required to be disclosed pursuant toA Rnengeuxluatrieo-n1 30 of the Listing
Regulations, read with the SEBI Master Circular No. SEBI/HO/49/14/14(7)2025-CFD-
POD2/I/3762/2026 dated January 30, 2026, are enclosed as .
The aforesaid disclosure is also being made available on the website of the Company at
www.thyrocare.com.
This is for your information and records.
Thyrocare Technologies Limited,
Y ours Faithfully,
Brijesh Kumar
Company Secretary and Compliance Officer
Annexure-1
D isclosure pursuant to Regulation 30 of the Listing Regulations, read with the SEBI
Master Circular No. SEBI/HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated
January 30, 2026:
Grant of Employee Stock Options (“Options”) under Thyrocare Employee Stock Option
Scheme (“Scheme”)
S. No. Particulars Details
1. Brief details of options granted; Grant of 1,92,000 (One Lakh Ninety-
Two Thousand Only) Options to the
eligible employees as determined by
the NRC.
2. Whether the scheme is in terms of SEBI Yes
(SBEB) Regulations, 2021 (if applicable);
3. Total number of shares covered by these 1,92,000 equity shares since each
options; Option is convertible into one (1)
equity share of the Company having
a face value of Rs. 10/- each subject
to the adjustments, if any, due to any
corporate actions in the Company as
mentioned in the Scheme.
4. Pricing formula/Exercise Price; The exercise price is Rs. 10/- per
Option as per the Scheme and as
approved by the NRC.
5. Options Vested (Vesting Schedule) Subject to the fulfillment of
conditions mentioned in the Scheme
and grant letter, one-third of the
Options granted shall vest at the end
of each year over three (3) years,
provided the employee remains in
continuous employment on the
respective vesting dates or as may be
determined by the NRC from time to
time.
6. Time within which option may be exercised Employees may exercise their
(Exercise Period); Options within (7) seven years from
the date of vesting, or any other
period approved by the NRC or the
Board as per the Scheme.
7. Brief details of significant terms; As per the Scheme
8. Options exercised; Not Applicable, as this intimation is
9. Money realized by exercise of options; pertaining to grant of Options under
10. The total number of shares arising as a the Scheme.
result of exercise of option;
11. Options lapsed;
12. Variation of terms of options;
13. Subsequent changes or cancellation or
exercise of such options;
14. Diluted earnings per share pursuant to
issue of equity shares on exercise of
options;